Bradley Herring Sells 24,443 Shares of Enfusion, Inc. (NYSE:ENFN) Stock

Enfusion, Inc. (NYSE:ENFN) CFO Bradley Herring sold 24,443 shares of the business’s stock in a transaction that occurred on Friday, December 20th. The stock was sold at an average price of $10.61, for a total value of $259,340.23. Following the sale, the chief financial officer now directly owns 270,503 shares in the company, valued at approximately $2,870,036.83. The trade was a 8.29 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Enfusion Stock Down 5.6 %

NYSE:ENFN opened at $10.09 on Friday. The stock has a fifty day simple moving average of $9.87 and a 200 day simple moving average of $9.06. The firm has a market capitalization of $1.30 billion, a price-to-earnings ratio of 252.31, a price-to-earnings-growth ratio of 3.98 and a beta of 0.97. Enfusion, Inc. has a 1-year low of $7.52 and a 1-year high of $11.38.

Analyst Ratings Changes

ENFN has been the topic of a number of research reports. Stifel Nicolaus boosted their price objective on Enfusion from $11.00 to $13.00 and gave the stock a “buy” rating in a research note on Wednesday, December 18th. Piper Sandler upped their price target on shares of Enfusion from $10.00 to $11.50 and gave the company a “neutral” rating in a report on Monday, December 23rd. Three equities research analysts have rated the stock with a sell rating, one has issued a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $10.25.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in ENFN. Scalar Gauge Management LLC lifted its position in shares of Enfusion by 21.8% in the 2nd quarter. Scalar Gauge Management LLC now owns 613,513 shares of the company’s stock valued at $5,227,000 after acquiring an additional 110,000 shares in the last quarter. Wellington Management Group LLP lifted its holdings in shares of Enfusion by 6.7% in the third quarter. Wellington Management Group LLP now owns 976,296 shares of the company’s stock valued at $9,265,000 after purchasing an additional 61,032 shares in the last quarter. Renaissance Technologies LLC boosted its position in shares of Enfusion by 167.6% in the second quarter. Renaissance Technologies LLC now owns 97,100 shares of the company’s stock worth $827,000 after buying an additional 60,811 shares during the period. PDT Partners LLC purchased a new position in shares of Enfusion during the third quarter valued at $867,000. Finally, Squarepoint Ops LLC acquired a new position in Enfusion during the second quarter valued at $683,000. 81.05% of the stock is currently owned by institutional investors and hedge funds.

About Enfusion

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.